Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation

Lei Gao; Yanqi Zhang; Baoyang Hu; Jia Liu; Peiyan Kong; Shifeng Lou; Yi Su; Tonghua Yang; Huimin Li; Yao Liu; Cheng Zhang; Li Gao; Lidan Zhu; Qin Wen; Ping Wang; Xinghua Chen; Jiangfan Zhong; Xi Zhang

doi:10.1200/JCO.2015.65.3642

Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation

Lei Gao, Yanqi Zhang, Baoyang Hu, Jia Liu, Peiyan Kong, Shifeng Lou, Yi Su, Tonghua Yang, Huimin Li, Yao Liu, Cheng Zhang, Li Gao, Lidan Zhu, Qin Wen, Ping Wang, Xinghua Chen, Jiangfan Zhong, Xi Zhang

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2843-2850
Number of pages	8
Journal	Journal of Clinical Oncology
Volume	34
Issue number	24
DOIs	https://doi.org/10.1200/JCO.2015.65.3642
State	Published - Aug 20 2016
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

Keywords

Graft vs Host Disease/etiology
Killer Cells, Natural/immunology
Hematopoietic Stem Cell Transplantation/adverse effects
Double-Blind Method
T-Lymphocytes/immunology
Humans
Mesenchymal Stem Cells/immunology
Male
Transplantation Conditioning/adverse effects
HLA Antigens/genetics
Mesenchymal Stem Cell Transplantation/methods
Transplantation, Homologous
Young Adult
Haploidy
B-Lymphocytes/immunology
Umbilical Cord/cytology
Adolescent
Adult
Female
Chronic Disease

Access to Document

10.1200/JCO.2015.65.3642

OpenUrl availability

Full text

Cite this

Gao, L., Zhang, Y., Hu, B., Liu, J., Kong, P., Lou, S., Su, Y., Yang, T., Li, H., Liu, Y., Zhang, C., Gao, L., Zhu, L., Wen, Q., Wang, P., Chen, X., Zhong, J., & Zhang, X. (2016). Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation. Journal of Clinical Oncology, 34(24), 2843-2850. https://doi.org/10.1200/JCO.2015.65.3642

Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation. / Gao, Lei; Zhang, Yanqi; Hu, Baoyang et al.
In: Journal of Clinical Oncology, Vol. 34, No. 24, 20.08.2016, p. 2843-2850.

Research output: Contribution to journal › Article › peer-review

Gao, L, Zhang, Y, Hu, B, Liu, J, Kong, P, Lou, S, Su, Y, Yang, T, Li, H, Liu, Y, Zhang, C, Gao, L, Zhu, L, Wen, Q, Wang, P, Chen, X, Zhong, J & Zhang, X 2016, 'Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation', Journal of Clinical Oncology, vol. 34, no. 24, pp. 2843-2850. https://doi.org/10.1200/JCO.2015.65.3642

Gao L, Zhang Y, Hu B, Liu J, Kong P, Lou S et al. Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation. Journal of Clinical Oncology. 2016 Aug 20;34(24):2843-2850. doi: 10.1200/JCO.2015.65.3642

@article{087ed222b8e14e299049782501d18ffe,

title = "Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation",

keywords = "Graft vs Host Disease/etiology, Killer Cells, Natural/immunology, Hematopoietic Stem Cell Transplantation/adverse effects, Double-Blind Method, T-Lymphocytes/immunology, Humans, Mesenchymal Stem Cells/immunology, Male, Transplantation Conditioning/adverse effects, HLA Antigens/genetics, Mesenchymal Stem Cell Transplantation/methods, Transplantation, Homologous, Young Adult, Haploidy, B-Lymphocytes/immunology, Umbilical Cord/cytology, Adolescent, Adult, Female, Chronic Disease",

author = "Lei Gao and Yanqi Zhang and Baoyang Hu and Jia Liu and Peiyan Kong and Shifeng Lou and Yi Su and Tonghua Yang and Huimin Li and Yao Liu and Cheng Zhang and Li Gao and Lidan Zhu and Qin Wen and Ping Wang and Xinghua Chen and Jiangfan Zhong and Xi Zhang",

note = "Publisher Copyright: {\textcopyright} 2016 by American Society of Clinical Oncology.",

year = "2016",

month = aug,

day = "20",

doi = "10.1200/JCO.2015.65.3642",

language = "English",

volume = "34",

pages = "2843--2850",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "24",

}

TY - JOUR

T1 - Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation

AU - Gao, Lei

AU - Zhang, Yanqi

AU - Hu, Baoyang

AU - Liu, Jia

AU - Kong, Peiyan

AU - Lou, Shifeng

AU - Su, Yi

AU - Yang, Tonghua

AU - Li, Huimin

AU - Liu, Yao

AU - Zhang, Cheng

AU - Gao, Li

AU - Zhu, Lidan

AU - Wen, Qin

AU - Wang, Ping

AU - Chen, Xinghua

AU - Zhong, Jiangfan

AU - Zhang, Xi

PY - 2016/8/20

Y1 - 2016/8/20

KW - Graft vs Host Disease/etiology

KW - Killer Cells, Natural/immunology

KW - Hematopoietic Stem Cell Transplantation/adverse effects

KW - Double-Blind Method

KW - T-Lymphocytes/immunology

KW - Humans

KW - Mesenchymal Stem Cells/immunology

KW - Male

KW - Transplantation Conditioning/adverse effects

KW - HLA Antigens/genetics

KW - Mesenchymal Stem Cell Transplantation/methods

KW - Transplantation, Homologous

KW - Young Adult

KW - Haploidy

KW - B-Lymphocytes/immunology

KW - Umbilical Cord/cytology

KW - Adolescent

KW - Adult

KW - Female

KW - Chronic Disease

UR - http://www.scopus.com/inward/record.url?scp=84982105626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982105626&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/f08b835c-bd11-324f-aa0d-f65e7b79df59/

U2 - 10.1200/JCO.2015.65.3642

DO - 10.1200/JCO.2015.65.3642

M3 - Article

C2 - 27400949

AN - SCOPUS:84982105626

SN - 0732-183X

VL - 34

SP - 2843

EP - 2850

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 24

ER -

Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this